MedTrace Logo

Ipsilateral Liver Lobe Devascularization of the Large Hepatocellular Carcinoma

NCT03129685 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2018-06-12

No results posted yet for this study

Summary

Assessment of short-term outcomes of ipsilateral lobe arterial devascularization of the large hepatocellular carcinoma: single center non-randomized trial.

Conditions

Interventions

PROCEDURE

HALED

This is attained via a laparotomy involves isolation of the arterial blood supply of the tumor-containing liver lobe (the ipsilateral hepatic artery as well as the extrahepatic arterial collaterals) while preserving the feeding veins.

Sponsors & Collaborators

  • The National Ribat University

    lead OTHER

Principal Investigators

  • Osama M Elsanousi, MD · Faculty of Medicine. The National Ribat University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-20
Primary Completion
2018-11-19
Completion
2018-12-19

Countries

  • Sudan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03129685 on ClinicalTrials.gov